Abstract Objectives: Application of the Charlson Comorbidity Index (CCI) on Egyptian
patients with head and neck cancer and determining whether it has effect on their overall …

Comorbid conditions are medical illnesses that accompany cancer. The impact of these
conditions on the outcome of patients with head and neck cancer is well established …

OBJECTIVES: Cancer patients have a wide range of comorbidities that are important
confounders for biomarker and clinical studies of prognosis and outcome. Comorbidities can …

Background Comorbidities are diseases or conditions that coexist with a disease of interest.
The importance of comorbidities is that they can alter treatment decisions, change resource …

Owing to the advance of supportive care and the development of molecular targeted
therapies, the elderlies or patients who have comorbidities have been treated more than …

Background Most patients with head and neck squamous cell carcinoma are older and may
have coexistent or comorbid diseases. Objectives To determine the prognostic impact of …

e18033 Background: Most patients (pts) with HNSCC are elderly and suffer from other
diseases that, similarly to cancer, are related to smoking and alcohol habit. Therefore, these …

Comorbidity, the presence of additional illnesses unrelated to the tumor, has a significant
impact on the prognosis of patients with head and neck cancer. In these patients, tobacco …

Comorbidities are diseases or conditions that co-exist with a disease of interest. The
importance of comorbidities is that they alter treatments, change resource utilization and …

We explored differences in prognostic ability for mortality of the established and validated
Charlson comorbidity index with two other comorbidity indexes developed for this study. Our …